Stay updated on Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial

Sign up to get notified when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added full trial details for the Port Delivery System study (design, criteria, outcomes, sites, and investigators). No deletions were reported.
    Difference
    100%
    Check dated 2025-10-15T02:51:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a government-operating status notice and updated version to v3.2.0; removed v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-07T23:13:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    - Version bumped from v3.0.2 to v3.1.0. - No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-30T02:46:31.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Updated to Revision: v3.0.2, replacing v3.0.1. The deletions include the prior revision tag and a Back to Top link, indicating a minor UI cleanup with no substantive changes to core content, pricing, stock, or time slots.
    Difference
    0.1%
    Check dated 2025-09-15T19:21:32.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-08T15:01:05.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as several new research articles related to the Port Delivery System with Ranibizumab. Notably, the previous location details have been removed, and several medical topics related to macular degeneration have also been deleted.
    Difference
    9%
    Check dated 2025-09-01T09:25:21.000Z thumbnail image

Stay in the know with updates to Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.